Possible attenuation of hypertrophic cardiomyopathy progression
An American trial investigated the potential of valsartan in slowing the course of disease in hypertrophic cardiomyopathy (HCM). The results showed a significantly positive influence on relative cardiac remodeling in the...
Read More